SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point after its recent earnings report, which, despite showing subscriber growth and exceeding revenue expectations, led to a notable sell-off. Community discussion is split between those viewing the price dip as an overreaction and a long-term buying opportunity, and those concerned about the cautious forward guidance, valuation, and the strategic implications of the potential Warner Bros. Discovery acquisition.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending significantly after Chairman Ryan Cohen increased his stake by purchasing an additional 500,000 shares, which the community views as a powerful signal of confidence. This insider move has ignited fervent speculation about upcoming strategic developments, further reinforced by the stock's notable resilience and positive performance even on days when the broader market is declining.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending amidst discussions surrounding President Trump's escalating rhetoric on acquiring Greenland, which includes threats of tariffs against opposing nations. This has sparked concerns over US government finances and international relations, with some European entities reportedly divesting from US Treasuries. Community sentiment is deeply divided, with many anticipating further market volatility and a potential "Sell America" trend, while others view the current downturn as an overreaction and a "buy the dip" opportunity.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened geopolitical tensions sparked by President Trump's aggressive rhetoric regarding Greenland and threats of new tariffs on European allies. This has fueled market volatility, with the community debating whether the current pullback is an overreaction or signals broader concerns, as attention also turns to upcoming BigTech earnings.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as reports indicate the U.S. government is establishing a new digital asset reserve to hold seized Bitcoin, shifting from prior selling policies and removing market pressure. This comes amidst heightened market volatility, which many in the community attribute to political rhetoric and broader macroeconomic concerns. Investor sentiment remains sharply divided, with intense debate around Bitcoin's role as a digital safe haven compared to traditional assets like gold and silver, while closely watching key technical support levels.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is seeing significant investor attention driven by its strategic pivot from Bitcoin mining to becoming a leading AI cloud infrastructure provider. The company's substantial power capacity and recent $9.7 billion Microsoft GPU cloud contract position it as a critical player in meeting the surging demand for AI compute. Community chatter highlights optimism for further hyperscaler partnerships and long-term growth, with many viewing IREN as undervalued despite market fluctuations.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is trending following a recent investor day that revealed significantly raised revenue targets and a substantial increase in backlog, prompting multiple analyst upgrades with considerably higher price targets. The community is buzzing about Ondas's strategic pivot to autonomous defense infrastructure, with many asserting the market has yet to fully price in its combat-proven technology and robust financial position. Investors are closely monitoring the integration of acquired assets and potential for major contract announcements in the rapidly evolving drone and counter-drone sectors.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively trending following its announced proposed public offering of common stock and warrants, which comes on the heels of an earlier surge driven by positive Phase 1 clinical trial data for its atopic dermatitis drug. The community is sharply divided, with many debating potential dilution and a subsequent price correction, while others view the offering as a strategic capital raise to advance a promising pipeline in a large market. This highlights the inherent tension for clinical-stage biotechs, balancing funding needs with encouraging early-stage therapeutic developments.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce is actively trending amid recent community discussions regarding unconfirmed reports about its CEO, though some perceive this news as outdated or strategically timed. The primary focus for many retail investors remains on the stock's extremely low public float and consistent insider buying, particularly by Vlad Galkin. This dynamic fuels ongoing conversations about potential market manipulation and the possibility of a significant short squeeze, with a strong belief that current valuations are suppressed.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

Top Wealth Group Holding is trending due to its announced acquisition of a wine authentication and trading business, aiming to diversify its luxury offerings, alongside a positive profit outlook. This news initially fueled a significant rally, but a recent public offering and sharp price volatility have deeply divided the community, with many now calling it a 

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 6.2% - Here's What Happened

Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 6.2% - Should You Sell...

Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 3.9% - What's Next?

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 3.9% - Here's Why...

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are covering the stock, Marketbeat.com reports. One...

Cullinan Therapeutics (NASDAQ:CGEM) CEO Sells $99,319.22 in Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) CEO Nadim Ahmed sold 9,922 shares of the firm's stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price...

Nadim Ahmed Sells 9,922 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) CEO Nadim Ahmed sold 9,922 shares of the business's stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average...

Assenagon Asset Management S.A. Has $1.05 Million Stake in Cullinan Therapeutics, Inc. $CGEM

Assenagon Asset Management S.A. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Free Report) by 1,665.9% in the third quarter, according to its most recent 13F filing with...

Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down - Time to Sell?

Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down - Time to Sell...

Jennifer Michaelson Sells 1,345 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 1,345 shares of the firm's stock in a transaction dated Friday, December 19th. The stock was sold at an...

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $13,463.45 in Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 1,345 shares of the business's stock in a transaction that occurred on Friday, December 19th. The shares...

Jeffrey Alan Jones Sells 4,632 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jeffrey Alan Jones sold 4,632 shares of the business's stock in a transaction dated Thursday, December 18th. The stock was sold at...

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$10.87
Prev Close	$10.72
Open	$10.70
Dividend Yield	0.00%
50-Day Moving Average	$10.13
Beta	1.13
Avg. Volume	1.18M
PE Ratio	-2.91

52-Week High	$13.33
52-Week Low	$5.68
Market Capitalization	$633.3M
EPS (Annual)	-$3.11
Price to Book	1.40
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

CGEM
Cullinan Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGEM News

CGEMCullinan Oncology Inc